AXSM

AXSM Earnings Preview

Axsome Therapeutics, Inc. · Healthcare · $10B

14d until earnings

AXSM Earnings

Monday, May 04 2026
EPS Estimate
$-0.76
$-0.96 – $-0.21
Revenue Estimate
$193M
Current Price
$188.99

Our Position

neutral

COO receives 19,663 RSUs in routine equity grant

structured data est. revisions rising (+34.6pp / 30d)

Routine equity grants are table stakes for C-suite retention, not a catalyst. This award suggests normal course compensation planning with no signaling value about company health or strategic direction.

Watch: Monitor whether equity grants accelerate or expand in size, which could signal retention concerns or major operational changes ahead. Watch for change-of-control language activation.

Data Signal Summary

2 bullish
2 bearish
Estimates up +2% Insider selling cluster Put/call 0.7 (bullish skew) Price downtrend

Key Context

Insider Activity
selling
Price Trend
downtrend
From 52w High
0.0%
Est. Revisions (30d)
+2.2% 1up/0dn
Analyst Target (mean)
$224 $199–$260 +19%
Options P/C Ratio
0.66
Est. Dispersion
99% 7 analysts
Insider Cluster
strong sell
Fund Convergence
strong D.E. Shaw, Citadel, Two Sigma, Renaissance, Bridgewater

Recent Activity

insider trades 55 transactions
Sell · COLEMAN MARK H (Director) ·25,000 shares ·$4,027,750
Sell · JACOBSON MARK L (Chief Operating Officer) ·35,378 shares ·$5,726,991
Exercise · JACOBSON MARK L (Chief Operating Officer) ·35,378 shares ·$100,827
Exercise · COLEMAN MARK H (Director) ·6,250 shares ·$30,938
Exercise · COLEMAN MARK H (Director) ·12,485 shares ·$61,801
50 more
Exercise · COLEMAN MARK H ·5,193 shr ·$41,648
Sell · TABUTEAU HERRIOT ·32,410 shr ·$6,015,296
Exercise · TABUTEAU HERRIOT ·32,410 shr ·$259,928
Sell · PIZZIE NICK ·12,000 shr ·$2,255,040
Exercise · PIZZIE NICK ·12,000 shr ·$42,000
Sell · MAIZEL ARI ·7,500 shr ·$1,383,300
Exercise · MAIZEL ARI ·7,500 shr ·$530,475
Sell · TABUTEAU HERRIOT ·139,414 shr ·$23,881,618
Exercise · TABUTEAU HERRIOT ·139,414 shr ·$1,118,100
Sell · SAAD MARK E ·37,577 shr ·$6,206,969
Exercise · SAAD MARK E ·37,577 shr ·$205,135
Sell · TABUTEAU HERRIOT ·79,973 shr ·$11,648,582
Exercise · TABUTEAU HERRIOT ·79,973 shr ·$641,383
Sell · TABUTEAU HERRIOT ·163,939 shr ·$21,815,669
Exercise · TABUTEAU HERRIOT ·163,939 shr ·$1,314,791
Sell · TABUTEAU HERRIOT ·45,384 shr ·$5,418,060
Exercise · TABUTEAU HERRIOT ·45,384 shr ·$363,980
Sell · JACOBSON MARK L ·10,000 shr ·$1,159,600
Exercise · JACOBSON MARK L ·10,000 shr ·$28,500
Sell · TABUTEAU HERRIOT ·62,880 shr ·$7,361,891
Exercise · TABUTEAU HERRIOT ·62,880 shr ·$504,298
Sell · JACOBSON MARK L ·45,783 shr ·$5,241,127
Exercise · JACOBSON MARK L ·40,000 shr ·$196,500
Buy · COLEMAN MARK H ·1,575 shr ·$200,466
Sell · SAAD MARK E ·9,127 shr ·$1,141,514
Exercise · SAAD MARK E ·9,127 shr ·$82,143
Sell · JEFFS ROGER A ·13,464 shr ·$1,665,228
Sell · JEFFS ROGER A ·60,000 shr ·$7,303,400
Sell · JEFFS ROGER A ·36,694 shr ·$4,405,216
Sell · MURDOCK HUNTER R ·13,514 shr ·$1,370,647
Exercise · MURDOCK HUNTER R ·13,514 shr ·$404,204
Sell · MURDOCK HUNTER R ·22,500 shr ·$2,276,850
Exercise · MURDOCK HUNTER R ·22,500 shr ·$672,975
Sell · JACOBSON MARK L ·25,000 shr ·$2,761,000
Exercise · JACOBSON MARK L ·25,000 shr ·$200,500
Sell · COLEMAN MARK H ·7,500 shr ·$783,375
Sell · JACOBSON MARK L ·40,673 shr ·$4,232,636
Exercise · JACOBSON MARK L ·40,673 shr ·$263,154
Sell · COLEMAN MARK H ·3,000 shr ·$322,473
Sell · PIZZIE NICK ·15,000 shr ·$1,951,530
Exercise · PIZZIE NICK ·15,000 shr ·$52,500
Exercise · COLEMAN MARK H ·9,127 shr ·$82,143
Exercise · COLEMAN MARK H ·33,410 shr ·$198,455
Sell · SAAD MARK E ·11,016 shr ·$1,005,871
Exercise · SAAD MARK E ·11,016 shr ·$40,429
Sell · JACOBSON MARK L ·47,739 shr ·$4,022,488
Exercise · JACOBSON MARK L ·47,739 shr ·$192,866
Sell · COLEMAN MARK H ·10,497 shr ·$789,107
Sell · JACOBSON MARK L ·7,910 shr ·$587,813
Exercise · JACOBSON MARK L ·13,693 shr ·$17,801